DoW Vision, Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA · Department of Defense · HT942526VRPCTA
In plain English
Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications for this grant until Nov 12, 2026 (1 day left).
The agency expects to make 1 award and estimated total program funding is $2,600,000.
Eligibility is listed as unrestricted (open to any type of applicant), subject to any clarification in the listing.
The listing says cost sharing or matching is not required.
Built only from the fields in the Grants.gov listing. Always confirm on the official listing.
Key facts
| Status | Posted: open for applications |
|---|---|
| Close date | Nov 12, 2026 · 1 day left |
| Posted date | May 5, 2026 |
| Opportunity number | HT942526VRPCTA |
| Agency | Defense Health Agency Contracting Activity - DHACA (Department of Defense) |
| Funding instrument | Grant |
| Category | Science and Technology and other Research and Development |
| Opportunity category | Discretionary |
| Award ceiling (max per award) | Not stated |
| Award floor (min per award) | Not stated |
| Estimated total program funding | $2,600,000 |
| Expected number of awards | 1 |
| Cost sharing or matching required | No |
| Assistance listing (CFDA/ALN) | 12.420 – Military Medical Research and Development |
| Last updated on Grants.gov | May 5, 2026 |
| Archive date | Dec 12, 2026 |
Who can apply
- Unrestricted (open to any type of entity above, subject to clarification in the listing)
Description
Excerpt from the official synopsis on Grants.gov (shortened; read the full text on the official listing):
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas . Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. …
More Department of Defense grants closing soon
All →- 1day leftDoW Spinal Cord Injury, Clinical Translation Research AwardUnrestricted eligibilityScience, technology and other research and development
- 1day leftDoW Spinal Cord Injury, Translational Research AwardUnrestricted eligibilityScience, technology and other research and development
- 1day leftDoW Vision, Translational Research AwardUnrestricted eligibilityScience, technology and other research and development
- 1day leftDoW Vision, Investigator-Initiated Research AwardUnrestricted eligibilityScience, technology and other research and development
More science, technology and other research and development grants closing soon
All →- 1day leftDoW Spinal Cord Injury, Clinical Trial AwardUnrestricted eligibilityScience, technology and other research and development
- 1day leftDoW Spinal Cord Injury, Investigator-Initiated Research AwardUnrestricted eligibilityScience, technology and other research and development
- 1day leftROSES 2025: C.2 Solar System ScienceScience, technology and other research and development
- 3days leftCooperative Agreement for affiliated Partner with Californian Cooperative Ecosystem Studies UnitScience, technology and other research and development